Friend turned foe: TREM2 agonist in battles against tau

3Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In this important study, Jain et al. (2022. J. Exp. Med. https://doi.org/10.1084/jem.20220654) find that chronic TREM2 activation by AL002a antibody exacerbates the seeding and spread of pathological tau, enhances the disease-associated microglial signature, and increases neurite dystrophy in 5xFAD mice seeded with Alzheimer’s disease tau.

Cite

CITATION STYLE

APA

Carling, G., Luo, W., & Gan, L. (2023). Friend turned foe: TREM2 agonist in battles against tau. Journal of Experimental Medicine, 220(1). https://doi.org/10.1084/jem.20221850

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free